Sculptured drug-eluting stent for the on-site delivery of tacrolimus

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 73, Issue 3, 2009, Pages 331-336

  Minghetti, Paola ^a   Cilurzo, Francesco ^a   Selmin, Francesca ^a   Casiraghi, Antonella ^a   Grignani, Andrea ^b   Montanari, Luisa ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b CID SrL   (Italy)

Author keywords

AFM; Drug eluting stent; Janus CarboStent; Tacrolimus

Indexed keywords

CARBON; EXCIPIENT; POLOXAMER; POLY(METHYL METHACRYLATE); POVIDONE; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATOMIC FORCE MICROSCOPY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG ELUTING STENT; DRUG RELEASE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MATERIAL COATING; NONHUMAN; PHYSICAL CHEMISTRY; RABBIT; RESERVOIR; SOLID STATE; SURFACE PROPERTY;

ANIMALS; CHEMISTRY, PHARMACEUTICAL; CRYSTALLIZATION; DRUG DELIVERY SYSTEMS; DRUG-ELUTING STENTS; EXCIPIENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; POLOXAMER; POLYMETHYL METHACRYLATE; POLYVINYLS; PYRROLIDINES; RABBITS; TACROLIMUS; TECHNOLOGY, PHARMACEUTICAL;

EID: 70350622594     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2009.08.004     Document Type: Article

References (18)

1. Sigwart U., Puel J., Mirkovitch V., Joffre F., and Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. New Engl. J. Med. 316 (1987) 701-706
2. van der Hoeven B.L., Pires N.M.M., Warda H.M., Oemrawsingh P.V., van Vlijmen B.J.M., Quax P.H.A., Schalij M.J., van der Wall E.E., and Jukema J.W. Drug eluting stents: results promises and problems. Int. J. Cardiol. 99 (2005) 9-17
3. Scott N.A. Restenosis following implantation of bare metal coronary stents: pathophysiology and pathways involved in the vascular response to injury. Adv. Drug Del. Rev. 58 (2006) 358-376
4. Wernick M.H., Jeremias A., and Carrozza J.P. Drug-eluting stents and stent thrombosis: a cause for concern?. Cor. Artery Dis. 17 (2005) 661-665
5. Burt H.M., and Hunter W.L. Drug-eluting stents: a multidisciplinary success story. Adv. Drug Del. Rev. 58 (2006) 350-357
6. Ge L., Cosgave J., Iokovou I., Sangiorgi G.M., and Colombo A. New drug-eluting stent technologies. Curr. Cardiol. Rev. 1 (2005) 953-968
7. Smith E.J., and Rothman M.T. Antiproliferative coatings for the treatment of coronary heart disease: what are the targets and which are the tools. J. Interv. Cardiol. 16 (2003) 475-483
8. Acharya G., and Park K. Mechanisms of controlled drug release from drug eluting stents. Adv. Drug Del. Rev. 58 (2006) 387-401
9. Bartorelli A.L., Trabattoni D., Fabbiocchi F., Montorsi P., De Martini S., Calligaris G., Teruzzi G., Galli S., and Ravagnani P. Synergy of passive coating and targeted drug delivery: the tacrolimus-eluting Janus CarboStent. J. Interv. Cardiol. 16 (2003) 499-505
10. Han Y.L., Wang S.L., Jing Q.M., Yu H.B., Wang B., Ma Y.Y., Luan B., and Wang G. Midterm outcomes of prospective randomized single-center study of the Janus tacrolimus-eluting stent for treatment of native coronary artery lesions. Chin. Med. J. 120 (2007) 552-556
11. Garcia-Tejada J., Gutierrez H., Albarran A., Hernandez F., Velazquez T., Rodriguez S., Gomez I., and Tascon J. Janus tacrolimus-eluting CarboStent. Immediate and medium-term clinical results. Rev. Espanola Cardiol. 60 (2007) 197-200
12. P. Minghetti, Kinetics and the mechanisms of release of target drugs acting against restenosis, in: 14th Annual Transcatheter Cardiovascular Therapeutics Symposium, Washington, DC, September 2002.
13. Kipshide N., Leon M.B., Tsapenko M., Falotico R., Kopia G., and Moses J. Update on Sirolimus drug-eluting stents. Curr. Pharm. Des. 10 (2003) 337-348
14. Stone G.W., Ellis S.G., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., Turco M., Caputo R., Bergin P., Greenberg J., Popma J.J., Russell M.E., and for the TAXUS-IV Investigators. One-year clinical results with the slow-release polymer-based paclitaxel-eluting TAXUS stent: the TAXUS-IV trial. Circulation 109 (2004) 1942-1947
15. Taga H., Tanaka H., Goto T., and Tada S. Structure of a new macrocyclic antibiotic. Acta Crystallogr. C: Cryst. Struct. Commun. C43 (1987) 751-753
16. Sinswat P., Overhoff K.A., McConville J.T., Johnston K.P., and Williams III R.O. Nebulization of nanoparticulate amorphous or crystalline tacrolimus - single dose pharmacokinetics study in mice. Eur. J. Pharm. Biopharm. 69 (2008) 1057-1066
17. Yamashita K., Nakate T., Okimoto K., Ohike A., Tokunaga Y., Ibuki R., Higaki K., and Kimur T. Establishment of new preparation method for solid dispersion formulation of tacrolimus. Int. J. Pharm. 267 (2003) 79-91
18. Craig D.Q.M. The mechanisms of drug release form solid dispersions in water soluble polymers. Int. J. Pharm. 231 (2002) 131-144